Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 14/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6096533 | 0.91 | ATM (0.42) | TACR1ATMKDM4EMAPTALDH1A1 | |
| SCHEMBL5820443 | 0.88 | TACR1 (0.36) | TACR1MAPTALDH1A1HPGD | |
| SCHEMBL4203119 | 0.87 | TACR1 (0.43) | TACR1 | |
| SCHEMBL8706262 | 0.87 | TACR1 (0.37) | TACR1MAPTALDH1A1HPGD | |
| SCHEMBL7193387 | 0.86 | TACR1 (0.41) | TACR1 | |
| SCHEMBL3821496 | 0.85 | TACR1 (0.37) | TACR1 | |
| SCHEMBL8322001 | 0.85 | TACR1 (0.38) | TACR1MAPT | |
| SCHEMBL7193383 | 0.84 | TACR1 (0.40) | TACR1 | |
| SCHEMBL5815553 | 0.83 | TACR1 (0.44) | TACR1 | |
| SCHEMBL8321997 | 0.83 | TACR1 (0.37) | TACR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006115286-A1 | PIPERIDINE DERIVATIVES, CRYSTAL, PROCESS FOR PRODUCING THE SAME, AND USE AS TACHIKININ RECEPTOR ANTAGONISTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-11-02 | — | — | WO | claimed |
| US-20240381529-A1 | METHOD FOR MANUFACTURING SUBSTRATE MATERIAL FOR SEMICONDUCTOR PACKAGE, PREPREG, AND APPLICATION FOR PREPREG | RESONAC CORPORATION (JP) | 2024-11-14 | — | — | US | disclosed |
| US-20240282684-A1 | SUBSTRATE AND METHOD FOR MANUFACTURING THE SAME | RESONAC CORPORATION (JP) | 2024-08-22 | — | — | US | disclosed |
| WO-2024111420-A1 | ALKALI-SOLUBLE RESIN, LIGHT-SENSITIVE RESIN COMPOSITION, METHODS RESPECTIVELY FOR PRODUCING THOSE, AND USE OF THOSE | 株式会社日本触媒 | 2024-05-30 | — | — | WO | disclosed |
| US-11990396-B2 | Substrate and method for manufacturing the same | RESONAC CORPORATION (JP) | 2024-05-21 | — | — | US | disclosed |
| CN-117980821-A | Photosensitive resin composition, photosensitive element, and method for producing laminate | 株式会社力森诺科 | 2024-05-03 | — | — | CN | disclosed |
| WO-2024053609-A1 | ALKALI-SOLUBLE RESIN, METHOD FOR PRODUCING SAME, PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT, MEMBER FOR DISPLAY DEVICE, AND DISPLAY DEVICE | 株式会社日本触媒 | 2024-03-14 | — | — | WO | disclosed |
| CN-117577592-A | Organic insertion body and method for manufacturing organic insertion body | 株式会社力森诺科 | 2024-02-20 | — | — | CN | disclosed |
| US-20230331946-A1 | METHOD FOR MANUFACTURING SUBSTRATE MATERIAL FOR SEMICONDUCTOR PACKAGE, PREPREG, AND SUBSTRATE MATERIAL FOR SEMICONDUCTOR PACKAGE | RESONAC CORPORATION (JP) | 2023-10-19 | — | — | US | disclosed |
| WO-2023190719-A1 | RESIN COMPOSITION, CURED PRODUCT, MULTILAYER BODY, TRANSPARENT ANTENNA AND IMAGE DISPLAY DEVICE | 株式会社レゾナック | 2023-10-05 | — | — | WO | disclosed |
| US-5750549-A | ANTIINFLAMMATORY AGENTS OR ANALGESICS | MERCK & CO., INC. (US) | 1998-05-12 | — | — | US | disclosed |
| EP-0829480-A2 | Tetrazolyl-substituted quinuclidines as substance P antagonists | PFIZER INC. (US) | 1998-03-18 | — | — | EP | disclosed |
| EP-0815104-A1 | 3-BENZYLAMINO-2-PHENYLPIPERIDINES AS NEUROKININ ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1998-01-07 | — | — | EP | disclosed |
| US-5703240-A | ANALGESICS; ANTIINFLAMMATORY AGENTS; NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS; GASTROINTESTINAL DISORDERS | GLAXO GROUP LIMITED (GB) | 1997-12-30 | — | — | US | disclosed |
| EP-0802912-A1 | PIPERIDINE DERIVATIVES HAVING TACHYKININ ANTAGONIST ACTIVITY | GLAXO GROUP LIMITED (GB) | 1997-10-29 | — | — | EP | disclosed |
| WO-1997014671-A1 | CYCLOPENTYL TACHYKININ RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | disclosed |
| WO-1996029326-A1 | 3-BENZYLAMINO-2-PHENYLPIPERIDINES AS NEUROKININ ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1996-09-26 | — | — | WO | disclosed |
| WO-1996021661-A1 | PIPERIDINE DERIVATIVES HAVING TACHYKININ ANTAGONIST ACTIVITY | GLAXO GROUP LIMITED (GB) | 1996-07-18 | — | — | WO | disclosed |
| EP-0720609-A1 | 3-(5-TETRAZOLYL-BENZYL)AMINO-PIPERIDINE DERIVATIVES AND ANTAGONISTS OF TACHYKININS | GLAXO GROUP LIMITED (GB) | 1996-07-10 | — | — | EP | disclosed |
| WO-1995008549-A1 | 3-(5-TETRAZOLYL-BENZYL)AMINO-PIPERIDINE DERIVATIVES AND ANTAGONISTS OF TACHYKININS | GLAXO GROUP LIMITED (GB) | 1995-03-30 | — | — | WO | disclosed |